0001628280-23-039366.txt : 20231116 0001628280-23-039366.hdr.sgml : 20231116 20231116175751 ACCESSION NUMBER: 0001628280-23-039366 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231115 FILED AS OF DATE: 20231116 DATE AS OF CHANGE: 20231116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeRosa Anthony John CENTRAL INDEX KEY: 0001868397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39417 FILM NUMBER: 231415805 MAIL ADDRESS: STREET 1: C/O EVOLV TECHNOLOGIES, INC. STREET 2: 500 TOTTEN POND ROAD, 4TH FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Evolv Technologies Holdings, Inc. CENTRAL INDEX KEY: 0001805385 STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER PERIPHERAL EQUIPMENT, NEC [3577] IRS NUMBER: 844473840 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12141 WICKCHESTER LN., SUITE 325 CITY: HOUSTON STATE: TX ZIP: 77079 BUSINESS PHONE: 212-653-0153 MAIL ADDRESS: STREET 1: 12141 WICKCHESTER LN., SUITE 325 CITY: HOUSTON STATE: TX ZIP: 77079 FORMER COMPANY: FORMER CONFORMED NAME: NewHold Investment Corp. DATE OF NAME CHANGE: 20200303 4 1 wk-form4_1700175462.xml FORM 4 X0508 4 2023-11-15 0 0001805385 Evolv Technologies Holdings, Inc. EVLV 0001868397 DeRosa Anthony John C/O EVOLV TECHNOLOGIES HOLDINGS, INC. 500 TOTTEN POND ROAD, 4TH FLOOR WALTHAM MA 02451 0 1 0 0 Chief Revenue Officer 1 Class A Common Stock 2023-11-15 4 M 0 10000 0.42 A 48832 D Class A Common Stock 2023-11-15 4 S 0 10000 4.04 D 38832 D Stock Option (Right to Buy) 0.42 2023-11-15 4 M 0 10000 0 D 2031-01-10 Class A Common Stock 10000 885540 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on March 15, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.91 to $4.17. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vests and becomes exercisable as to 25% of the shares on October 1, 2021 and in 36 equal monthly installments thereafter. /s/ Eric Pyenson, Attorney-in-fact for Anthony John DeRosa 2023-11-16